Search Results

Prime Therapeutics LLC and Magellan Rx Management launched Pharmacy Match, a technology-enabled specialty pharmacy solution designed to drive competition through an expanded specialty pharmacy network and to lower drug costs for plan sponsors.

BioMatrix Specialty Infusion Pharmacy (“BioMatrix” or “The Company”) announced today the sale of the majority interests of the company from Acon Investments & Triton Pacific Healthcare to Frazier Healthcare Partners (“Frazier”).

Orsini Specialty Pharmacy, and Zevra Therapeutics, Inc. announced that Orsini is now the pharmacy partner for OLPRUVA® for oral suspension.

Vizient, Inc. hosted its inaugural Insight: Cell, Gene, and Specialty Pharmacy Symposium, bringing together leading healthcare providers, payers and manufacturers of high-cost, ultra-specialty pharmaceuticals along with other stakeholders to discuss the promise and unique challenges of the rapidly expanding market of cell, gene and other advanced therapies.

Mycovia Pharmaceuticals, Inc., an emerging biopharmaceutical company, announced that patients now have exclusive access to VIVJOA® through AllianceRx Walgreens Pharmacy and Walgreens community-based specialty pharmacies, subsidiaries of Walgreens Boots Alliance, Inc.

BioMatrix Specialty Pharmacy is pleased to announce the appointment of Ted Kramm to the Board of Directors.